Stockreport

Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc. [Yahoo! Finance]

Lisata Therapeutics, Inc.  (LSTA) 
PDF Lisata Therapeutics, Inc. Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cas [Read more]